The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

COPENHAGEN, Denmark, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced financial results ...

We are now in crisis again because of Donald Trump’s executive order freezing aid. Surely local drug manufacture now needs to be implemented without any further delay?

A new survey from the ABPI has revealed a surge in apprenticeships, placements and global research collaborations in the UK ...

DMU will be part of a consortium laying the foundation for future medicines that are affordable, safe, effective, and ...

Today, adoption of digital health faces some of the same barriers — scepticism, budget limitations, high expectations, and a ...

The settlement in U.S. v. Gilead could disturb the model of public-private partnership that sustains many of the United ...

Pharmaceutical company Takeda is pioneering a technology-enabled, patient-centered future for plasma-derived therapies ...

As the Q4 2024 pharma earnings period rolls on through the first month of President Donald Trump’s second term, executives ...

The finest minds from the pharma firmament will also be sharing insights on the changing landscape and on the new imperatives ...

In a landmark achievement for both Uganda and the global medical community, the United States Patent and Trademark Office ...

With Chinese firms becoming major players in drug development, the traditional balance of power in global pharmaceuticals is ...